Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
89 Cards in this Set
- Front
- Back
Strength of interaction between drug and its receptor
|
Affinity
|
|
Amount of drug necessary to elicit a biologic effect
|
Potency
|
|
Antidote used for cyanide poisoning
|
Nitrites
|
|
Antidote used for iron salt toxicity
|
Deferoxamine
|
|
Antidote for methotrexate toxicity
|
Leucovorin
|
|
MOA of cisplatin
|
Alkylating agent
|
|
Anticancer drug also used in RA, produces acrolein in urine that leads to hemorrhagic cystitis
|
Cyclophosphamide
|
|
Used for hairy cell leukemia; it stimulates NK cells
|
Interferon alpha
|
|
Produces disulfiram-like reaction with ethanol
|
Procarbazine
|
|
Vitamins containing iron should NOT be taken simultaneously with levothyroxine because
|
Iron deiodinates thyroxine
|
|
Long acting GC's
|
Betamethasone, dexamethasone, and paramethasone
|
|
Inhibits conversion of cholesterol to pregnenolone therefore inhibiting corticosteroid synthesis
|
Aminoglutethimide
|
|
Antifungal agent used for inhibition of all gonadal and adrenal steroids
|
Ketoconazole
|
|
Antiprogestin used as potent antagonist of GC receptor
|
Mifepristone
|
|
Anti-androgen used for hirsutism in females
|
Cyproterone acetate
|
|
Long acting insulin
|
Ultralente (humulin U)
|
|
Examples of alpha-glucosidase inhibitors (AGI)
|
Acarbose, miglitol
|
|
Amino acid derivative, active as an insulin secretagogue
|
Nateglinide
|
|
Most important potential SE of metformin
|
Lactic acidosis
|
|
MOA of thiazolindinediones
|
Stimulate PPAR-gamma receptor to regulate CHO and lipid metabolism
|
|
Only bisphosphonates available IV
|
Etidronate
|
|
1st generation antihistamine that is highly sedating
|
Diphenhydramine
|
|
H1 blocker that is also a serotonin antagonist
|
Cyproheptadine
|
|
Drug causing depletion of substance P (vasodilator)
|
Capsaicin
|
|
Inhibitor of lipoxygenase
|
Zileuton
|
|
Long acting beta 2 agonist used in asthma
|
Salmeterol
|
|
Muscarinic antagonist used in asthma
|
Ipratropium
|
|
MOA of corticosteroids"
|
inhibit phospholipase A2
|
|
Type of resistance found with vancomycin
|
Point mutation
|
|
Meningitis prophylaxis in exposed patients
|
Rifampin
|
|
MOA of sulfonamides
|
Inhibit dihydropteroate synthase
|
|
PCN active against pseudomonas
|
Carbenicillin, piperacillin and ticarcillin
|
|
Treatment of resistant pseudomembranous colitis
|
ORAL vancomycin
|
|
Common side effect of Rifampin
|
Red urine discoloration
|
|
Antivirals that are teratogens
|
Delavirdine, efavirenz, and ribavirin
|
|
HIV med used to reduce transmission during birth
|
AZT (zidovudine)
|
|
Drug used for N. gonorrhea in females
|
Ceftriaxone
|
|
MOA of erythromycin
|
Inhibition of protein synthesis at the 50s subunit of ribosome
|
|
Benzodiazepine used for anxiety
|
Alprazolam
|
|
Neurologic SE of benzodiazepines
|
Anterograde amnesia
|
|
Benzodiazepine that is used for anesthesia
|
Midazolam
|
|
Agent with zero-order kinetics
|
Ethanol
|
|
MOA for Ethosuximide
|
Calcium channels
|
|
Drug of choice for myoclonic seizures
|
Valproic acid
|
|
SE for Felbamate
|
Aplastic anemia and acute hepatic failure
|
|
Benzodiazepine used adjunctively in anesthesia
|
Midazolam
|
|
Drug used in neuroleptic malignant syndrome
|
Dantrolene
|
|
Antipsychotic having the strongest autonomic effects
|
Thioridazine
|
|
Antidepressant associated with seizures and cardiotoxicity
|
Maprotiline
|
|
Bronchodilation in asthma and COPD
|
Ipratropium
|
|
Antidote for lead poisoning
|
EDTA (or EDTA and dimercarprol)
|
|
Antidote for organophosphate/anticholinesterase poisoning
|
atropine, pralidoxime (2-PAM)
|
|
Antidote for opioid toxicity
|
naloxone iv, naltrexone po
|
|
MOA of cisplatin
|
alkylating agent
|
|
Regimen used for non-hodgkins lymphoma
|
CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) plus rituximab)
|
|
Microtubule inhibitor that causes peripheral neuropathy, foot drop (eg. ataxia), and "pins and needles" sensation
|
vincristine
|
|
acth analog used for dx of pt’s with corticosteroid abnormality
|
cosyntropin
|
|
Synthetic analog of ADH hormone used for diabetes insipidus and nocturnal enuresis
|
desmopressin
|
|
Common SE of spironolactone
|
hyperkalemia, gynecomastia
|
|
Prototype of H1 and H2 receptors
|
diphenhydramine and cimetidine
|
|
Agents used in carcinoid tumor
|
Ketanserin cyproheptadine, and phenoxybenzamine
|
|
DOC to treat chemo-induced nausea and vomiting
|
odansetron
|
|
Ergot alkaloid used as an illicit drug
|
LSD
|
|
Prostaglandin used in tx of impotence
|
alprostadil
|
|
Methylxanthine derivative used as a remedy for intermittent claudication
|
Pentoxifylline
|
|
Meningitis prophylaxis in exposed pts
|
rifampin
|
|
Technique used to diagnose perianal itching, and the drug used to treat it
|
scotch tape technique, mebendazole
|
|
MOA sulfonamides
|
inhibit dihydropteroate synthase
|
|
Anemia caused by trimethoprim
|
megalobolastic anemia
|
|
Drug used in chagas disease
|
nifurtimox
|
|
Drugs of chose for leprosy
|
Dapsone, rifampin and clofazimine combination
|
|
Antibiotic frequently used for chronic UTI prophylaxis
|
sulfamethoxazole/trimethoprim
|
|
Activation of these receptors close Ca2+ ion channels to inhibit neurotransmitter release
|
Presynaptic mu, delta, and kappa receptors
|
|
this agent used to treat dry mouth in Sjogren’s syndrome
|
cevimeline
|
|
Organophosphate anthelmintic agent with long DOA
|
metrifonate
|
|
Most toxic organophosphate
|
parathione
|
|
Tx of motion sickness
|
Meclizine, Scopolamine (M,S=motion sickness)
|
|
Losartan and valsartan block
|
angiotensin receptors
|
|
Methyldopa is contraindicated in
|
geriatrics due to CNS depression
|
|
MOA thiazide diuretics
|
inhibit Na/Cl cotransport
|
|
SE procainamide
|
lupus like syndrome
|
|
DOC for management of acute ventricular arrhythmias
|
amiodarone
|
|
DOC for paroxysmal supraventricular tachycardia; has high efficacy and short
|
adenosine
|
|
SE of sotalol
|
QT and PR prolongation
|
|
Topical DOC in impetigo
|
Topical mupirocin (Bactroban)
|
|
MOA of class III antiarrhythmics
|
K channel blockade
|
|
MOA of class IV antiarrhythmics
|
Ca channel blockers
|
|
Specific pharmacokinetic characteristic of amiodarone
|
Prolonged half-life, up to six weeks
|
|
Rapid acting insulins that do not self aggregate-
|
Lispro insulin, Aspart insulin, Glulisine insulin (fast, insulins L A G)
|